Clinical testing panels for ALS: global distribution, consistency, and challenges.

MLA

Dilliott, Allison A., et al. “Clinical Testing Panels for ALS: Global Distribution, Consistency, and Challenges.” Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 24, no. 5/6, Aug. 2023, pp. 420–35. EBSCOhost, https://doi.org/10.1080/21678421.2023.2173015.

APA

Dilliott, A. A., Al Nasser, A., Elnagheeb, M., Fifita, J., Henden, L., Keseler, I. M., Lenz, S., Marriott, H., Mccann, E., Mesaros, M., Opie-Martin, S., Owens, E., Palus, B., Ross, J., Wang, Z., White, H., Al-Chalabi, A., Andersen, P. M., Benatar, M., & Blair, I. (2023). Clinical testing panels for ALS: global distribution, consistency, and challenges. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 24(5/6), 420–435. https://doi.org/10.1080/21678421.2023.2173015

Chicago

Dilliott, Allison A., Ahmad Al Nasser, Marwa Elnagheeb, Jennifer Fifita, Lyndal Henden, Ingrid M. Keseler, Steven Lenz, et al. 2023. “Clinical Testing Panels for ALS: Global Distribution, Consistency, and Challenges.” Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration 24 (5/6): 420–35. doi:10.1080/21678421.2023.2173015.